Mustafa Özdoğan

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Effect of Iron Deficiency Anemia on the Levels of Hemoglobin A1c in Nondiabetic Patients

Erkan Çoban, Mustafa Özdoğan, Ayşen Timurağaoğlu · Acta Haematologica · 2004 · 299 citations

Iron Metabolism, Iron Deficiency Anemia, Iron Deficiency +18

The mean platelet volume in patients with obesity

Erkan Çoban, Mustafa Özdoğan, G. Yazicioglu et al. · International Journal of Clinical Practice · 2005 · 289 citations

The mean platelet volume in subjects with impaired fasting glucose

Erkan Çoban, Feyzi Bostan, Mustafa Özdoğan · Platelets · 2005 · 121 citations

Hypertension, Mean Platelet Volume, Obesity +20

Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy

Hakan Bozcuk, Gülcan Uslu, Mustafa Samur et al. · Cytokine · 2004 · 104 citations

Metabolic Syndrome, Serum Insulin Correlate, Breast Oncology +9